Bright Minds Biosciences (DRUG) Institutional Ownership $36.78 +0.18 (+0.49%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Bright Minds Biosciences (NASDAQ:DRUG)CurrentInstitutional OwnershipPercentage40.52%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$28.87KNumber ofInstitutional Sellers(last 12 months)0 Get DRUG Insider Trade Alerts Want to know when executives and insiders are buying or selling Bright Minds Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DRUG Institutional Buying and Selling by Quarter Bright Minds Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024AdvisorShares Investments LLC188,119$273K0.1%+12.0%4.246% 11/6/2023AdvisorShares Investments LLC167,930$267K0.1%-67.4%4.452% 8/9/2023AdvisorShares Investments LLC515,315$294K0.1%+14.7%14.640% 5/9/2023AdvisorShares Investments LLC449,155$198K0.1%+42.7%2.553% 8/8/2022AdvisorShares Investments LLC289,576$237K0.1%+40.1%2.439% 5/9/2022AdvisorShares Investments LLC206,716$314K0.1%+115.5%1.745% 2/9/2022Checchi Capital Advisers LLC14,138$45K0.0%N/A0.119% 1/31/2022AdvisorShares Investments LLC95,942$304K0.0%N/A0.810% (Data available from 1/1/2016 forward) DRUG Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DRUG shares? During the previous two years, the following institutional investors and hedge funds held shares of Bright Minds Biosciences shares: AdvisorShares Investments LLC ($273K).Learn more on DRUG's institutional investors. What percentage of Bright Minds Biosciences stock is owned by institutional investors? 40.52% of Bright Minds Biosciences stock is owned by institutional investors. Learn more on DRUG's institutional investor holdings. Which institutional investors have been buying Bright Minds Biosciences stock? The following institutional investors have purchased Bright Minds Biosciences stock in the last 24 months: AdvisorShares Investments LLC ($220.64K). How much institutional buying is happening at Bright Minds Biosciences? Institutional investors have bought a total of 220,641 shares in the last 24 months. This purchase volume represents approximately $512.97K in transactions. Which Bright Minds Biosciences major shareholders have been selling company stock? The following institutional investors have sold Bright Minds Biosciences stock in the last 24 months: AdvisorShares Investments LLC ($347.39K). How much institutional selling is happening at Bright Minds Biosciences? Institutional investors have sold a total of 347,385 shares in the last 24 months. This volume of shares sold represents approximately $555.82K in transactions. Related Companies Immunome Institutional Ownership Evolus Institutional Ownership Autolus Therapeutics Institutional Ownership Erasca Institutional Ownership ORIC Pharmaceuticals Institutional Ownership VectivBio Institutional Ownership Kura Oncology Institutional Ownership Tectonic Therapeutic Institutional Ownership CARGO Therapeutics Institutional Ownership Humacyte Institutional Ownership This page (NASDAQ:DRUG) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRUG Stock Alerts